Trial · NCT03016598
Results by group174
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 174
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Positive: Baseline | 9 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Positive: Baseline | 12 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Positive: Week 1 | 9 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Positive: Week 1 | 10 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Postive: Week 2 | 10 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Postive: Week 2 | 11 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Positive: Week 3 | 8 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Positive: Week 3 | 11 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Positive: Week 4 | 8 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Positive: Week 4 | 12 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Positive: Week 5 | 9 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Positive: Week 5 | 12 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Positive: Week 6 | 9 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Positive: Week 6 | 11 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Oxytocin | Stimulant Positive: Week 7 | 9 | Participants | |
| Number of Participants With Stimulant Positive Drug Screen | Placebo | Stimulant Positive: Week 7 | 11 | Participants | |
| Working Alliance Inventory (WAI) | Oxytocin | WAI Week 1: Self-Report | 3.5972 | Standard Deviation 0.8816 | score on a scale |
| Working Alliance Inventory (WAI) | Placebo | WAI Week 1: Self-Report | 3.8182 | Standard Deviation 0.8107 | score on a scale |
| Working Alliance Inventory (WAI) | Oxytocin | WAI Week 7: Self-Report | 3.4676 | Standard Deviation 0.785 | score on a scale |
| Working Alliance Inventory (WAI) | Placebo | WAI Week 7: Self-Report | 3.5208 | Standard Deviation 1.0516 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03016598/results